GoodRx Holdings, Inc. planned insider sales
In the last twelve months insiders at GoodRx Holdings, Inc. filed 2 Form 144 notices of planned sales, 2.8 million shares worth $10.4 million at the time of filing, from 2 sellers. The latest, filed 19 August 2026: Francisco Partners GP IV, L.P. (10% stockholder, affiliate), 2.8 million shares worth $10.3 million, planned for around 19 August 2026 through Merrill Lynch, Pierce,Fenner & Smith Incorporated.
| Filed | Seller | Relationship | Shares | Value | Planned sale | Sold, per Form 4 | Broker | How acquired | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 19 August 2026 | Francisco Partners GP IV, L.P. | 10% Stockholder, Affiliate | 2,760,995 | $10.3 million | 19 August 2026 | 2,760,995 shares from 19 August 2026 | Merrill Lynch, Pierce,Fenner & Smith Incorporated | Class A Common Stock received upon conversion of Class B Common Stock originally purchased on 10/15/2015 | Form 144 |
| 13 May 2026 | Ian Thornton Clark | Director | 43,100 | $111,620 | 13 May 2026 | No matching Form 4 sale | Morgan Stanley Smith Barney LLC Executive Financial Services | Restricted Stock | Form 144 |
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.